Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Lytham Partners Spring 2021 Investor Conference
 Tuesday, March 30, 2021
 5:00pm EDT